A size and shape tuned, multifunctional metal chalcogenide, Cu 2 S-based nanotheranostic agent is developed for trimodal imaging and multimodal therapeutics against brain cancer cells. This theranostic agent was highly efficient in optical, photoacoustic and x-ray contrast imaging systems. The folate targeted, NIRresponsive photothermal ablation in synergism with the chemotherapeutic action of doxorubicin proved to be a rapid precision guided cancer-killing module. The multistimuli, i.e., pH-, thermo-and photo-responsive drug release behavior of the nanoconjugates opens up a wider corridor for on-demand, triggered drug administration. The simple synthesis protocol, combined with the multitudes of interesting features packed into a single nanoformulation, clearly demonstrates the competing role of this Cu 2 S nanosystem in future cancer treatment strategies.
Solid tumors, due to their multilevel intricacies and vast diversity in genetic content, protein expression, and cellular/tissue microenvironment are considered to be one of the most urgent challenging health issues. [1] [2] [3] Several therapeutic approaches have been developed and adopted to target malignancy and exterminate them for good. 4, 5 Unfortunately, even after continuous progress in the research and development of such strategies, malignancy continues to evolve with a high recurrence rate. 6 Of the various options for identifying and treating cancer, nanotechnology has been a promising prospect to reckon with. [7] [8] [9] [10] Main objectives of nanotechnology in medicine, nanomedicine, for cancer therapy include specific identification of cancerous cells from the vast number and diversity of normal cells surrounding the tumor, augmenting the therapeutic ability of the drugs, and tracing the location of the drug/cargo inside the biological system. [11] [12] [13] Initially, nanoparticles (NPs) for therapeutics were formulated solely to transport drugs to lesion sites without any added functionalities. [14] [15] [16] However recent advances in nanotechnology have nurtured the engineering of precision nanomaterials with multiple, discrete function-related components integrated into a single nanosystem for efficient biomedical applications. [17] [18] [19] [20] [21] These multifunctional nanocarriers could dramatically overhaul the treatment and diagnostic options for cancer and there is an ever-increasing interest in developing the same. A variety of such carriers have already been investigated with substantially improved cancer theranostics that can harbor therapeutics, fluorescent moieties and utilize the inherent signature properties of the carrier. [22] [23] [24] Additional conjugation to aptamers, antibodies, peptides etc., renders high level of cellular specificity to the nanocarrier, which could be utilized for focusing on the desired cells and negating non-specific cellular adhesion and or internalization. [25] [26] [27] [28] Few examples of recently reported theranostic agents include a multifunctional magnetic-plasmonic nanoagent that possess magnetic resonance and photoacoustic imaging guided tumor photothermal therapy property; 29 LDL labeled Au nanocrystals (NCs) that help the analysis and localization of LDL in vivo using multimodal whole body computed and spectral imaging; 30 indicates the advantageous pH responsive behavior of the nanoconstruct applicable in triggered drug release. This observation can be attributed primarily to the amine group present in DOX that protonates at low pH, rendering it hydrophilic and leading to faster release. Such a phenomenon is highly advantageous, as it would enhance therapeutic efficacy specifically at acidic pH, which is a hallmark of cancer tissues.
Therefore at the physiological pH of normal cells, the release of DOX from NCs will be limited or non-existent. This minimizes the non-specific spread of toxic drugs leading to efficient anti-cancer therapy. According to the obtained data the photothermal conversion efficiency of PEG-Cu 2 S
NCs was calculated to be ∼25.3%. 47 To test whether the temperature rise can guide the release of drug, we investigated the thermo-responsive drug release behavior. 
